Low-Dose Oral Minoxidil for Androgenetic Alopecia Is Not Associated with Significant Changes in Alcohol Consumption: A Retrospective Study of 21,971 Patients.
{"title":"Low-Dose Oral Minoxidil for Androgenetic Alopecia Is Not Associated with Significant Changes in Alcohol Consumption: A Retrospective Study of 21,971 Patients.","authors":"Michael M Ong, Zachary Neubauer, Shari R Lipner","doi":"10.1159/000543710","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Oral minoxidil, used off-label for androgenetic alopecia, has been linked to alcohol hangover symptoms. We examined changes in alcohol consumption before and after low-dose oral minoxidil (LDOM) initiation.</p><p><strong>Methods: </strong>Using Epic's Cosmos database (2010-2024), we analyzed alcohol consumption 6 months pre- and post-minoxidil in patients with recorded data. A two-sample <i>z</i> test compared average daily alcohol intake.</p><p><strong>Results: </strong>Among 21,971 patients, demographics and minoxidil dosing were similar between groups. Average alcohol consumption was unchanged pre- versus post-LDOM (0.264 vs. 0.260 drinks/day, <i>p</i> = 0.72).</p><p><strong>Conclusion: </strong>LDOM does not significantly affect alcohol consumption, suggesting minimal impact on hangover symptoms. Prospective studies are needed, but patients can be reassured about the low likelihood of symptom exacerbation.</p>","PeriodicalId":21844,"journal":{"name":"Skin Appendage Disorders","volume":"11 5","pages":"441-444"},"PeriodicalIF":1.3000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500294/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Skin Appendage Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000543710","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Oral minoxidil, used off-label for androgenetic alopecia, has been linked to alcohol hangover symptoms. We examined changes in alcohol consumption before and after low-dose oral minoxidil (LDOM) initiation.
Methods: Using Epic's Cosmos database (2010-2024), we analyzed alcohol consumption 6 months pre- and post-minoxidil in patients with recorded data. A two-sample z test compared average daily alcohol intake.
Results: Among 21,971 patients, demographics and minoxidil dosing were similar between groups. Average alcohol consumption was unchanged pre- versus post-LDOM (0.264 vs. 0.260 drinks/day, p = 0.72).
Conclusion: LDOM does not significantly affect alcohol consumption, suggesting minimal impact on hangover symptoms. Prospective studies are needed, but patients can be reassured about the low likelihood of symptom exacerbation.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
